Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Correlation between microtubule-associated gene expression and chemosensitivity of patients with stage II non-small cell lung cancer.

Jiang H, Yu XM, Zhou XM, Wang XH, Su D.

Exp Ther Med. 2013 May;5(5):1506-1510. Epub 2013 Mar 14.

PMID:
23737908
[PubMed]
Free PMC Article
2.

High expression levels of class III β-tubulin in resected non-small cell lung cancer patients are predictive of improved patient survival after vinorelbine-based adjuvant chemotherapy.

Zhang Y, Yang H, Liu J, Deng Q, He P, Lin Y, Jiang J, Gu X, Mo M, Pan H, Xiong X, Qiu Y, He J.

Oncol Lett. 2013 Jul;6(1):220-226. Epub 2013 Apr 29.

PMID:
23946808
[PubMed]
Free PMC Article
3.

[Expression and predictive role of excision repair cross complementation group 1, ribonucleotide reductase subunit M1, and β-tubulin 3 in postoperative patients with non-small cell lung cancer receiving adjuvant chemotherapy].

Shi Y, Chen L, Li J, Lü YL, Jiao SC.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Aug;32(4):375-82. doi: 10.3881/j.issn.1000-503X.2010.04.004. Chinese.

PMID:
20868593
[PubMed - indexed for MEDLINE]
Free Article
4.

[Relationship between Expression of beta-tubulin-III Plus Stathmin in Advanced Non-Small Cell Lung Cancer and its Sensitivity to Venorelbine Chemotherapy.].

Pu X, Wang J, Xu L, Ma J, Wang Z, Liu F, Yang M, Fan W, Meng L.

Zhongguo Fei Ai Za Zhi. 2009 Jan 20;12(1):49-53. doi: 10.3779/j.issn.1009-3419.2009.01.008. Chinese.

PMID:
20712957
[PubMed]
Free Article
5.

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.

Rosell R, Scagliotti G, Danenberg KD, Lord RV, Bepler G, Novello S, Cooc J, Crinò L, Sánchez JJ, Taron M, Boni C, De Marinis F, Tonato M, Marangolo M, Gozzelino F, Di Costanzo F, Rinaldi M, Salonga D, Stephens C.

Oncogene. 2003 Jun 5;22(23):3548-53.

PMID:
12789263
[PubMed - indexed for MEDLINE]
6.

Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.

Sève P, Isaac S, Trédan O, Souquet PJ, Pachéco Y, Pérol M, Lafanéchère L, Penet A, Peiller EL, Dumontet C.

Clin Cancer Res. 2005 Aug 1;11(15):5481-6.

PMID:
16061864
[PubMed - indexed for MEDLINE]
Free Article
7.

Association between class III β-tubulin expression and response to paclitaxel/vinorebine-based chemotherapy for non-small cell lung cancer: a meta-analysis.

Zhang HL, Ruan L, Zheng LM, Whyte D, Tzeng CM, Zhou XW.

Lung Cancer. 2012 Jul;77(1):9-15. doi: 10.1016/j.lungcan.2012.01.005. Epub 2012 Feb 4. Review.

PMID:
22306125
[PubMed - indexed for MEDLINE]
8.

Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma.

Aoki D, Oda Y, Hattori S, Taguchi K, Ohishi Y, Basaki Y, Oie S, Suzuki N, Kono S, Tsuneyoshi M, Ono M, Yanagawa T, Kuwano M.

Clin Cancer Res. 2009 Feb 15;15(4):1473-80. doi: 10.1158/1078-0432.CCR-08-1274.

PMID:
19228748
[PubMed - indexed for MEDLINE]
Free Article
9.

[Correlation of the expression of III β-tubulin and MDR1 protein with biological features of non-small cell lung cancer].

Hu LH, Wu Y, Lu GH, Chen QY, Wang YH, Zhou JY.

Zhonghua Zhong Liu Za Zhi. 2010 Oct;32(10):762-6. Chinese.

PMID:
21163067
[PubMed - indexed for MEDLINE]
10.

Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.

Azuma K, Sasada T, Kawahara A, Takamori S, Hattori S, Ikeda J, Itoh K, Yamada A, Kage M, Kuwano M, Aizawa H.

Lung Cancer. 2009 Jun;64(3):326-33. doi: 10.1016/j.lungcan.2008.09.002. Epub 2008 Nov 1.

PMID:
18977553
[PubMed - indexed for MEDLINE]
11.

Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation.

Azuma K, Sasada T, Kawahara A, Hattori S, Kinoshita T, Takamori S, Ichiki M, Imamura Y, Ikeda J, Kage M, Kuwano M, Aizawa H.

Cancer Chemother Pharmacol. 2009 Aug;64(3):565-73. doi: 10.1007/s00280-008-0907-3. Epub 2009 Jan 3.

PMID:
19123003
[PubMed - indexed for MEDLINE]
12.

Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10.

Sève P, Lai R, Ding K, Winton T, Butts C, Mackey J, Dumontet C, Dabbagh L, Aviel-Ronen S, Seymour L, Whitehead M, Tsao MS, Shepherd FA, Reiman T.

Clin Cancer Res. 2007 Feb 1;13(3):994-9.

PMID:
17289895
[PubMed - indexed for MEDLINE]
Free Article
13.

Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology.

Jeong SH, Lee HW, Han JH, Kang SY, Choi JH, Jung YM, Choi H, Oh YT, Park KJ, Hwang SC, Sheen SS, Oh YJ, Kim JH, Lim HY.

Jpn J Clin Oncol. 2008 Oct;38(10):661-9. doi: 10.1093/jjco/hyn089. Epub 2008 Sep 4.

PMID:
18772168
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Class III beta-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel.

Sève P, Mackey J, Isaac S, Trédan O, Souquet PJ, Pérol M, Lai R, Voloch A, Dumontet C.

Mol Cancer Ther. 2005 Dec;4(12):2001-7.

PMID:
16373715
[PubMed - indexed for MEDLINE]
Free Article
15.

beta-Tubulin III mRNA expression and docetaxel sensitivity in non-small cell lung cancer.

Wang LF, Yin HT, Qian XP, Wei J, Zhao Y, Yu LX, Liu BR.

Clin Invest Med. 2009 Dec 1;32(6):E278.

PMID:
20003833
[PubMed - indexed for MEDLINE]
16.

Beta-tubulin isotype classes II and V expression patterns in nonsmall cell lung carcinomas.

Cucchiarelli V, Hiser L, Smith H, Frankfurter A, Spano A, Correia JJ, Lobert S.

Cell Motil Cytoskeleton. 2008 Aug;65(8):675-85. doi: 10.1002/cm.20297.

PMID:
18613117
[PubMed - indexed for MEDLINE]
17.

Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel.

Su D, Smith SM, Preti M, Schwartz P, Rutherford TJ, Menato G, Danese S, Ma S, Yu H, Katsaros D.

Cancer. 2009 Jun 1;115(11):2453-63. doi: 10.1002/cncr.24282.

PMID:
19322891
[PubMed - indexed for MEDLINE]
Free Article
18.

Expression of ERCC1 and class III β-tubulin is associated with the survival of resected stage III non-small cell lung cancer patients treated with induction chemoradiotherapy using carboplatin-taxane.

Huang CL, Kadota K, Liu D, Ueno M, Nakasima N, Ishikawa S, Gotoh M, Misaki N, Chang SS, Yokomise H.

Exp Ther Med. 2010 May;1(3):445-451. Epub 2010 May 1.

PMID:
22993560
[PubMed]
Free PMC Article
19.

Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype.

Tseden-Ish M, Choi YD, Cho HJ, Ban HJ, Oh IJ, Kim KS, Song SY, Na KJ, Ahn SJ, Choi S, Kim YC.

Respirology. 2012 Jan;17(1):127-33. doi: 10.1111/j.1440-1843.2011.02060.x.

PMID:
21899657
[PubMed - indexed for MEDLINE]
Free Article
20.

Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.

Chen P, Li J, Ge LP, Dai CH, Li XQ.

Respirology. 2010 Apr;15(3):501-9. doi: 10.1111/j.1440-1843.2010.01710.x. Epub 2010 Feb 24.

PMID:
20210890
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk